Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page shows a minor version bump from v3.4.0 to v3.4.1, a routine update with no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T11:21:12.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Show glossary option added and QC-related labels updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The earlier entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-29T03:57:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Recruitment status updated from Recruiting to Active, not recruiting; the locations count is updated to 18 and multiple contact details and site listings were removed or updated.
    Difference
    7%
    Check dated 2026-01-21T03:57:49.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 updated from v3.3.3. No functional changes are indicated.
    Difference
    0.0%
    Check dated 2026-01-14T02:23:17.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Arizona, Florida, Kentucky, Massachusetts, Michigan, Missouri, New York, Ohio, Pennsylvania, Texas, Wisconsin, Alberta, and Quebec; removed the prior individual location subsections; version updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:14:50.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision history update: added Revision v3.3.2 and removed Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T16:58:45.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.